Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kent

Showing results (201-210 of 259) with videos related to

Pageof 26
Sort By:
Neuron|March 17, 2015
Photosensitivity of neurons enabled by cell-targeted gold nanoparticlesJoão L Carvalho-de-Souza, Jeremy S Treger, Bobo Dang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?Eva Karam, Justin Laporte, Scott R Solomon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2016
Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute LeukemiaScott R Solomon, Connie A Sizemore, Xu Zhang, et al.
Biopolymers|January 29, 2016
Total Chemical Synthesis of an Orf Virus Protein, ORFV002, an Inhibitor of the Master Gene Regulator NF-κBS J Son, P W R Harris, C J Squire, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2015
Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling DonorsScott R Solomon, Connie A Sizemore, Melissa Sanacore, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 28, 2006
Central and peripheral renin-angiotensin systems in ouabain-induced hypertensionWarren J Cheung, Mary-Anne H Kent, Esraa El-Shahat, et al.
ACS Omega|June 2, 2020
Visualizing Tetrahedral Oxyanion Bound in HIV-1 Protease Using Neutrons: Implications for the Catalytic Mechanism and Drug DesignMukesh Kumar, Kalyaneswar Mandal, Matthew P Blakeley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2012
Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trialScott R Solomon, Connie A Sizemore, Melissa Sanacore, et al.
Advances in Hematology|April 16, 2021
A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic MalignanciesMelhem M Solh, Gabriel Hinojosa, Justin Laporte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantationAsad Bashey, Xu Zhang, Connie A Sizemore, et al.
Pageof 26

Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
Neuron|March 17, 2015
Photosensitivity of neurons enabled by cell-targeted gold nanoparticlesJoão L Carvalho-de-Souza, Jeremy S Treger, Bobo Dang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?Eva Karam, Justin Laporte, Scott R Solomon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2016
Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute LeukemiaScott R Solomon, Connie A Sizemore, Xu Zhang, et al.
Biopolymers|January 29, 2016
Total Chemical Synthesis of an Orf Virus Protein, ORFV002, an Inhibitor of the Master Gene Regulator NF-κBS J Son, P W R Harris, C J Squire, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2015
Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling DonorsScott R Solomon, Connie A Sizemore, Melissa Sanacore, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 28, 2006
Central and peripheral renin-angiotensin systems in ouabain-induced hypertensionWarren J Cheung, Mary-Anne H Kent, Esraa El-Shahat, et al.
ACS Omega|June 2, 2020
Visualizing Tetrahedral Oxyanion Bound in HIV-1 Protease Using Neutrons: Implications for the Catalytic Mechanism and Drug DesignMukesh Kumar, Kalyaneswar Mandal, Matthew P Blakeley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 7, 2012
Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trialScott R Solomon, Connie A Sizemore, Melissa Sanacore, et al.
Advances in Hematology|April 16, 2021
A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic MalignanciesMelhem M Solh, Gabriel Hinojosa, Justin Laporte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantationAsad Bashey, Xu Zhang, Connie A Sizemore, et al.
Pageof 26